Fisher Scientific Co. LLC, Houston, Texas, has been awarded a maximum $34,344,000 fixed-price, indefinite-delivery/indefinite-quantity contract for nucleic acid amplification COVID-19 test supplies. This was a competitive acquisition with two responses received. This is an 18-month contract with no option periods. Location of performance is Texas, with a March 23, 2023, ordering period end date. Using customers are Customs and Border Patrol sector stations and associated facilities, emergency intake shelters, Office of Refugee Resettlement shelters and other federally funded customers. Type of appropriation is fiscal 2021 through 2023 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-21-D-0047).